New hope for diabetes patients

My Account
Logout

Create an Evening Standard Account

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Welcome! Sign in here

Use your social network

Save time by using your existing account to sign in to Evening Standard

We'll never share your information or post anything to your account without your permission

Forgot your password ?

Registration

* indicates fields that are mandatory

Email *

Password *

Confirm Password *

First name *

Surname *

Postcode *

Country *

Mobile phone number

Username *

Gender *

Year of birth *

When you sign up...

You will have access to all our online competitions, discounted offers and can post comments on our site.

You will also receive The Weekender newsletter sent every Thursday - it’s full of fantastic offers and ideas for the weekend. You can update your email preferences in your account page when you log in.

Other newsletters and emails

Homes & Property Newsletter - Yes I want to receive the weekly email with all the latest news on property in the capital

Occasionally we would also like to send you relevant emails detailing specific offers either from ourselves or carefully selected partners. If you would prefer not to receive these then please tick the appropriate boxes below. We will never pass on your details.

I do not want to receive additional offers and information from the Evening Standard

I do not want to receive additional offers and information sent by Evening Standard on behalf of carefully selected partners

Terms and Conditions

* I have read, understood and agree to be bound by the terms and conditions of Evening Standard

Registration

Mail Sent for Registration Confirmation.

A confirmation email has been sent. Please activate your account by clicking on the activation link sent in your mail box.

A pooled data study involving almost 90,000 participants found that a wide range of patients benefited from the treatment, irrespective of what kind of diabetes they had.

Over an average period of 4.3 years, deaths among diabetes sufferers fell by 9% for every step reduction in "bad" cholesterol levels.

People without diabetes experienced a death rate reduction that was only slightly higher.

The number of major cardiovascular events such as heart attacks and strokes fell by a fifth for every millimole per litre reduction in blood levels of low density lipoprotein (LDL), or "bad" cholesterol.

Again the effect was similar in people with and without diabetes.

Diabetes is known to increase the risk of heart and artery disease. However although previous research has supported the its treatment with statins, the effect of the drugs on major coronary events including death has not been clear.

It was also uncertain whether statins were as effective for diabetic patients as for those without the disease.

Researchers from the Oxford-based Cholesterol Treatment Trialists Collaboration, working with colleagues in Australia, pooled together and analysed results from 14 randomised trials. The studies included 18,686 patients with both Type 1 and Type 2 diabetes, and 71,370 without diabetes.

Writing in The Lancet medical journal, the authors concluded: "This meta-analysis shows convincingly that the proportional benefits of statin therapy on major vascular events were similar in a wide range of individuals with diabetes, including those with no previous history of vascular disease, and benefits were similar to those observed in people without diabetes."